GO:0006954 |
BP |
Inflammatory response |
18 |
9.11E−9 |
0.0000088 |
GO:0006955 |
BP |
Immune response |
18 |
4.26E−8 |
0.0000412 |
GO:0032496 |
BP |
Response to lipopolysaccharide |
9 |
0.0000513 |
0.04832 |
GO:0002523 |
BP |
Leukocyte migration involved in inflammatory response |
4 |
0.0000782 |
0.072795 |
GO:0007155 |
BP |
Cell adhesion |
14 |
0.0000787 |
0.073195 |
GO:0002576 |
BP |
Platelet degranulation |
7 |
0.000175 |
0.155654 |
GO:0030198 |
BP |
Extracellular matrix organization |
9 |
0.000178 |
0.157584 |
GO:0050729 |
BP |
Positive regulation of inflammatory response |
6 |
0.000292 |
0.245789 |
GO:0006935 |
BP |
Chemotaxis |
7 |
0.000438 |
0.344834 |
GO:0071294 |
BP |
Cellular response to zinc ion |
4 |
0.000438 |
0.345355 |
GO:0045926 |
BP |
Negative regulation of growth |
4 |
0.000438 |
0.345355 |
GO:0045600 |
BP |
Positive regulation of fat cell differentiation |
5 |
0.00053 |
0.400817 |
GO:0050832 |
BP |
Defense response to fungus |
4 |
0.001263 |
0.705093 |
GO:0060326 |
BP |
Cell chemotaxis |
5 |
0.001801 |
0.824787 |
GO:0030593 |
BP |
Neutrophil chemotaxis |
5 |
0.001906 |
0.841641 |
GO:0010043 |
BP |
Response to zinc ion |
4 |
0.002927 |
0.941058 |
GO:0001501 |
BP |
Skeletal system development |
6 |
0.004843 |
0.990808 |
GO:0007165 |
BP |
Signal transduction |
19 |
0.00503 |
0.992337 |
GO:0002437 |
BP |
Inflammatory response to antigenic stimulus |
3 |
0.0062 |
0.997541 |
GO:0030178 |
BP |
Negative regulation of Wnt signaling pathway |
4 |
0.008258 |
0.999668 |
GO:0007263 |
BP |
Nitric oxide‐mediated signal transduction |
3 |
0.009889 |
0.999932 |
GO:0071356 |
BP |
Cellular response to tumor necrosis factor |
5 |
0.011676 |
0.999988 |
GO:0001666 |
BP |
Response to hypoxia |
6 |
0.012312 |
0.999994 |
GO:0050776 |
BP |
Regulation of immune response |
6 |
0.014105 |
0.999999 |
GO:0035924 |
BP |
Cellular response to vascular endothelial growth factor stimulus |
3 |
0.014331 |
0.999999 |
GO:0002035 |
BP |
Brain renin‐angiotensin system |
2 |
0.015897 |
1 |
GO:0070488 |
BP |
Neutrophil aggregation |
2 |
0.015897 |
1 |
GO:0006952 |
BP |
Defense response |
4 |
0.016421 |
1 |
GO:0032868 |
BP |
Response to insulin |
4 |
0.016421 |
1 |
GO:0050900 |
BP |
Leukocyte migration |
5 |
0.016519 |
1 |
GO:0001816 |
BP |
Cytokine production |
3 |
0.016818 |
1 |
GO:0035987 |
BP |
Endodermal cell differentiation |
3 |
0.019474 |
1 |
GO:0042476 |
BP |
Odontogenesis |
3 |
0.019474 |
1 |
GO:0032689 |
BP |
Negative regulation of interferon‐gamma production |
3 |
0.020864 |
1 |
GO:0010033 |
BP |
Response to organic substance |
3 |
0.020864 |
1 |
GO:0071549 |
BP |
Cellular response to dexamethasone stimulus |
3 |
0.022294 |
1 |
GO:0007204 |
BP |
Positive regulation of cytosolic calcium ion concentration |
5 |
0.022427 |
1 |
GO:1900625 |
BP |
Positive regulation of monocyte aggregation |
2 |
0.023751 |
1 |
GO:2001179 |
BP |
Regulation of interleukin‐10 secretion |
2 |
0.023751 |
1 |
GO:0032602 |
BP |
Chemokine production |
2 |
0.023751 |
1 |
GO:0070295 |
BP |
Renal water absorption |
2 |
0.023751 |
1 |
GO:1902042 |
BP |
Negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
3 |
0.0284 |
1 |
GO:0042742 |
BP |
Defense response to bacterium |
5 |
0.028971 |
1 |
GO:0030307 |
BP |
Positive regulation of cell growth |
4 |
0.029638 |
1 |
GO:0002793 |
BP |
Positive regulation of peptide secretion |
2 |
0.031543 |
1 |
GO:0032673 |
BP |
Regulation of interleukin‐4 production |
2 |
0.031543 |
1 |
GO:0032119 |
BP |
Sequestering of zinc ion |
2 |
0.031543 |
1 |
GO:0072593 |
BP |
Reactive oxygen species metabolic process |
3 |
0.031676 |
1 |
GO:0018108 |
BP |
Peptidyl‐tyrosine phosphorylation |
5 |
0.034254 |
1 |
GO:0045786 |
BP |
Negative regulation of cell cycle |
3 |
0.035093 |
1 |
GO:0042493 |
BP |
Response to drug |
7 |
0.03518 |
1 |
GO:0007160 |
BP |
Cell‐matrix adhesion |
4 |
0.035316 |
1 |
GO:0006953 |
BP |
Acute‐phase response |
3 |
0.038646 |
1 |
GO:0002381 |
BP |
Immunoglobulin production involved in immunoglobulin‐mediated immune response |
2 |
0.039273 |
1 |
GO:0008285 |
BP |
Negative regulation of cell proliferation |
8 |
0.039604 |
1 |
GO:0043408 |
BP |
Regulation of mitogen‐activated protein kinase cascade |
3 |
0.042329 |
1 |
GO:0002548 |
BP |
Monocyte chemotaxis |
3 |
0.044219 |
1 |
GO:0045429 |
BP |
Positive regulation of nitric oxide biosynthetic process |
3 |
0.046139 |
1 |
GO:0010042 |
BP |
Response to manganese ion |
2 |
0.046942 |
1 |
GO:0038084 |
BP |
Vascular endothelial growth factor signaling pathway |
2 |
0.046942 |
1 |
GO:0005576 |
CC |
Extracellular region |
44 |
2.35E−14 |
3.22E−12 |
GO:0005615 |
CC |
Extracellular space |
40 |
4.29E−14 |
5.89E−12 |
GO:0005887 |
CC |
Integral component of plasma membrane |
32 |
2.71E−8 |
0.00000371 |
GO:0005886 |
CC |
Plasma membrane |
56 |
0.00000132 |
0.000181 |
GO:0009897 |
CC |
External side of plasma membrane |
10 |
0.0000284 |
0.003882 |
GO:0031093 |
CC |
Platelet alpha‐granule lumen |
5 |
0.000713 |
0.093083 |
GO:0005578 |
CC |
Proteinaceous extracellular matrix |
8 |
0.003704 |
0.398509 |
GO:0070062 |
CC |
Extracellular exosome |
32 |
0.011945 |
0.807247 |
GO:0030666 |
CC |
Endocytic vesicle membrane |
4 |
0.012698 |
0.826358 |
GO:0031012 |
CC |
Extracellular matrix |
7 |
0.02228 |
0.954358 |
GO:0030669 |
CC |
Clathrin‐coated endocytic vesicle membrane |
3 |
0.03651 |
0.993875 |
GO:0048471 |
CC |
Perinuclear region of cytoplasm |
10 |
0.039931 |
0.996238 |
GO:0004872 |
MF |
Receptor activity |
10 |
0.0000321 |
0.009231 |
GO:0050786 |
MF |
RAGE receptor binding |
4 |
0.0000611 |
0.017515 |
GO:0004908 |
MF |
Interleukin‐1 receptor activity |
3 |
0.001097 |
0.271869 |
GO:0005201 |
MF |
Extracellular matrix structural constituent |
4 |
0.013171 |
0.97833 |
GO:0017147 |
MF |
Wnt protein binding |
3 |
0.02166 |
0.998215 |
GO:0004896 |
MF |
Cytokine receptor activity |
3 |
0.028658 |
0.999776 |
GO:0035662 |
MF |
Toll‐like receptor 4 binding |
2 |
0.029063 |
0.999801 |
GO:0004982 |
MF |
N‐formyl peptide receptor activity |
2 |
0.029063 |
0.999801 |
GO:0008201 |
MF |
Heparin binding |
5 |
0.030385 |
0.999866 |
GO:0008083 |
MF |
Growth factor activity |
5 |
0.031597 |
0.999907 |
GO:0004714 |
MF |
Transmembrane receptor protein tyrosine kinase activity |
3 |
0.031677 |
0.999909 |
GO:0050544 |
MF |
Arachidonic acid binding |
2 |
0.036196 |
0.999976 |
GO:0005160 |
MF |
Transforming growth factor‐beta receptor binding |
3 |
0.03807 |
0.999987 |
GO:0005178 |
MF |
Integrin binding |
4 |
0.042233 |
0.999996 |
GO:0042803 |
MF |
Protein homodimerization activity |
11 |
0.042565 |
0.999997 |
GO:0004875 |
MF |
Complement receptor activity |
2 |
0.043278 |
0.999997 |